Anicom Holdings,Inc. Q3 FY2026 earnings call

• Three-Stage Evolution of Pet Insurance

  • Insurance 1.0 (current legacy model): Focused exclusively on post-illness/injury financial reimbursement of veterinary costs. Management notes this model creates a perverse incentive that can encourage unhealthy behavior and does not deliver actual customer satisfaction, since receiving claims confirms a pet has become ill or injured.
  • Insurance 2.0 (short-term strategic goal): A prevention-focused model that improves pet immune health to reduce disease incidence. The company has identified that consistent consumption of a single fixed processed kibble diet and lack of consistent dental care create elevated immune suppression in pets, leading to higher rates of early-onset cancer and life-threatening gastrointestinal illness. Insurance 2.0 initiatives include promoting varied daily diets and consistent oral hygiene to strengthen immunity and extend healthy pet lifespan.
  • Insurance 3.0 (medium/long-term strategic goal): Integrate insurance and advanced veterinary care to deliver lower-pain, lower-sequelae, higher-success-rate treatment when illness cannot be prevented, leveraging mechanization and AI to reduce costs and improve outcomes.

• Core Competitive Advantage in Pet Insurance

  • Management explains that unlike auto insurance where secondary channels (policy renewal at vehicle replacement) deliver better underwriting results, pet insurance has concentrated pre-existing health conditions in secondary channels (when owners seek coverage after a pet develops health concerns). Stable underwriting therefore requires focus on primary channels (acquisition when a pet is first obtained from a breeder or pet store).
  • Anicom addresses breeder/pet store needs for veterinary care for their inventory animals, which most competing insurers do not do, thanks to Anicom's large in-house team of veterinarians. This in-house veterinary capacity also allows Anicom to effectively detect and prevent fraudulent insurance claims, a more common issue in pet insurance than many other insurance lines due to smaller claim sizes and lower regulatory scrutiny.
  • Proactive public health initiatives, such as widespread education of breeders to avoid genetic crosses that cause degenerative myelopathy in Welsh Corgis, have allowed the company to nearly eliminate this disease in Japan and build strong brand equity.

• JARVIS Tokyo Advanced Veterinary Facility

  • This is the centerpiece of Anicom's second founding era and Insurance 3.0 initiative. It is a world-first model that features fully transparent, glass-walled operating rooms, public disclosure of surgical outcomes, and use of AI to reduce pain, reduce complications, and improve surgical success rates.
  • The facility currently occupies 2 floors of an 8-story building, with space to expand to the full building as demand grows. It is modeled after large, world-renowned standalone veterinary hospitals in the United States.
  • Transparency is a core operating principle: surgical activity is fully visible, and any mistakes are not hidden, which improves accountability and drives continuous improvement of clinical skills across the facility.

No detailed segmented financial figures are provided in this transcript. The transcript notes that Anicom Holdings has achieved steady year-on-year revenue and profit growth over its 25-year history, and has maintained the No.1 position in the Japanese pet insurance market despite widespread entry of competing life and non-life insurers over the past decade. For its new JARVIS Tokyo advanced veterinary medical facility: (1) 0.5 billion yen in annualized revenue was reached 2 months and 2 weeks after opening in October 2025; (2) the facility is targeting 5 billion yen in annual revenue at full scale, which will exceed the break-even point.

• For JARVIS Tokyo: Management expects to reach 5 billion yen in annual revenue, which will exceed the facility's break-even point. Once break-even is crossed, the capital-intensive facility is expected to deliver very high marginal profits, with a projected internal rate of return (IRR) of 30%, which exceeds Anicom's historical investment return on existing projects.
• Management expects continued extension of pet lifespans as Insurance 2.0 prevention initiatives gain traction, with expected growth in demand for advanced veterinary care for age-related complex conditions.
• The company is targeting long-term industry leadership by pioneering automated/AI-assisted pet surgery, starting with the animal-focused model that can advance more quickly than human-focused surgical automation given regulatory constraints on human medical procedures.

• Strategic risk: If automated/AI-assisted surgical innovation does not deliver on expected cost and outcome improvements, the large capital investment in JARVIS Tokyo could result in prolonged unprofitability, as capital-intensive advanced medical facilities have high break-even requirements.
• Regulatory risk: Legal and regulatory liability rules act as a major barrier to adoption of automated surgical procedures, similar to the existing barrier for human surgical automation, which could slow innovation and adoption of Insurance 3.0 models.
• Underwriting risk: Failure to maintain focus on primary channel distribution could lead to adverse selection and worsening underwriting results, as secondary channel pet insurance business has significantly higher concentrations of pre-existing conditions.
• Operational risk: Fraudulent insurance claims are more prevalent in pet insurance than many other insurance lines, which can erode profitability if detection and prevention efforts are insufficient.

Q: What is the core difference between Anicom's three stages of insurance development? / A: Insurance 1.0 is traditional reimbursement for veterinary costs after a pet gets sick or injured. Insurance 2.0 shifts to prevention, working to improve pet health so they do not get sick in the first place. Insurance 3.0 integrates insurance and direct medical provision to deliver better, lower-cost advanced care when prevention fails. This three-stage evolution aligns with the company's 25-year history and current second founding strategic shift.

Q: Why has Anicom been able to maintain market leadership despite widespread entry of large competing insurers into the Japanese pet insurance market? / A: The key advantage is understanding the unique distribution dynamic of pet insurance, where the secondary channel (acquiring new customers after a pet develops health concerns) creates adverse selection. Focusing on the primary channel (when pets are first acquired) requires providing veterinary services to breeders and pet stores, which competitors do not do thanks to Anicom's large in-house team of veterinarians. This in-house expertise also allows Anicom to detect and prevent insurance fraud far more effectively than competitors.

Q: Can you explain how Insurance 2.0 addresses the unexpectedly high rates of early-onset cancer and gastrointestinal death in pets? / A: Anicom's 25 years of claims data found that young pets have higher-than-expected immune suppression, which drives higher disease rates. The root cause is that pets eat the same fixed kibble diet every day from weaning onward, which does not build the diverse immune system needed to fight disease. Adding lack of dental care, which allows periodontal bacteria to enter the bloodstream and suppress gut immunity, creates double disease risk. Insurance 2.0 promotes varied diets and regular oral care to strengthen immunity.

Q: What is the core purpose of the new JARVIS Tokyo facility? / A: JARVIS Tokyo is the flagship of Insurance 3.0, integrating insurance and direct provision of advanced veterinary care instead of just reimbursing for external care. It pioneers transparent, open surgery with published outcomes, uses AI and mechanization to improve success rates and reduce pain and complications, and acts as a test bed for automated surgical innovation that cannot advance as quickly in human medicine due to regulation. Early performance has exceeded expectations, with strong initial revenue.